PIDD logo

Diagnosis: A Practical Patient Scenario for Primary Care Providers

Designed for Primary Care Providers (PCPs), this patient scenario invites learners to conduct an initial telehealth visit and determine, based on clinical history and presenting symptoms, which tests to run and whether there are patterns of immunodeficiency that indicate the patient should be referred to an Allergy/Immunology Specialist. We encourage Allergy/Immunology Specialists or advanced practice providers to also complete this case.


Diagnosis of PIDD is often delayed due to missed patterns of immunodeficiency and critical documentation of the patient’s history and other quality of life factors. This patient case will provide an opportunity to apply knowledge gained in the Signs & Symptoms and Telehealth modules. Learners will be introduced virtually to a suspected PIDD patient and make decisions about how to communicate with and determine appropriate next steps for the patients. Learners will receive feedback on the decisions they make throughout the case.  


Providing Enhanced Medical Support for Patients with Primary Immunodeficiency Disorders (PIDD) is funded through an educational grant from Pfizer. 

Target Audience

  • Allergist/Immunologists
  • Primary Care Providers
  • Fellows-in-Training
  • Nurses and Nurse Practitioners
  • Physician Assistants and Other Allied Health Professionals 

Learning Objectives

Upon completion of this activity, participants should be able to:

  1. In a virtual patient scenario, identify signs and symptoms that might indicate PIDD 
  2. Determine if the virtual patient should be referred to an A/I specialist  
  3. Perform differential diagnosis for the virtual patient  
Summary
Available credit: 
  • 0.50 Attendance
    Attendance credit.
  • 0.50 CE
    CE credit.
  • 0.50 CME
    CME credit.
Course opens: 
08/26/2021
Course expires: 
06/30/2022
Cost:
$0.00
Rating: 
0
Accreditation Statement

The American Academy of Allergy, Asthma and Immunology (AAAAI) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

The American Academy of Allergy, Asthma & Immunology designates this activity for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CE Designation Statement

The American Academy of Allergy, Asthma, & Immunology (AAAAI) is a Provider, approved by the California Board of Registered Nursing, Provider #10704, for up to 0.50 Contact Hours.

Credit Claiming Period (Online courses and recordings)

Credit claiming for the online courses associated with this activity will expire at 11:59 pm on June 30, 2022. Requests to claim credit on or after July 1, 2022 will be denied.

Medium and Method of Physician Participation for an Online Course or Webinar Recording

Follow these steps to complete the activity:

  1. Register for the activity.
  2. Review the CME and Disclosure information.
  3. Complete all required components.
  4. Complete the activity evaluation.
AAAAI Privacy Policy

To verify your participation in educational activities, you may be asked to provide your name, contact information, and/or other descriptors. The AAAAI will not release this information to outside entities. It may be used internally to inform you of other AAAAI educational activities. If you wish to have your information excluded from this process, please contact us at cme@aaaai.org.

Questions

Registration and credit claiming questions should be directed to cme@aaaai.org.

Available Credit

  • 0.50 Attendance
    Attendance credit.
  • 0.50 CE
    CE credit.
  • 0.50 CME
    CME credit.

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

One of the two latest versions of Google Chrome, Microsoft Edge, Mozilla Firefox, or Safari.

Internet Explorer is no longer supported.